• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Suppressive antibiotic treatment with dalbavancin. A case report].

作者信息

Barbero Allende J M, García Sánchez M, Culebras López A M, Agudo Alonso R

机构信息

José María Barbero Allende. Servicio de Medicina Interna. Hospital Universitario Príncipe de Asturias. Alcalá de Henares. C/ Fray Luis de León 5A, 3ºC, 28012, Madrid. Spain.

出版信息

Rev Esp Quimioter. 2021 Apr;34(2):151-153. doi: 10.37201/req/105.2020. Epub 2021 Jan 25.

DOI:10.37201/req/105.2020
PMID:33491409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8019464/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/8019464/9e6a0355082e/revespquimioter-34-151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/8019464/5a465a211202/revespquimioter-34-151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/8019464/9e6a0355082e/revespquimioter-34-151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/8019464/5a465a211202/revespquimioter-34-151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/8019464/9e6a0355082e/revespquimioter-34-151-g002.jpg

相似文献

1
[Suppressive antibiotic treatment with dalbavancin. A case report].[用达巴万星进行抑制性抗生素治疗。病例报告]
Rev Esp Quimioter. 2021 Apr;34(2):151-153. doi: 10.37201/req/105.2020. Epub 2021 Jan 25.
2
Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature.达巴万星作为植入物相关感染的抑制性治疗：一项伴有治疗药物监测的病例系列研究，并对文献进行回顾。
Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1475-1480. doi: 10.1007/s10096-024-04849-0. Epub 2024 May 16.
3
Current trends in the real-life use of dalbavancin: report of a study panel.临床应用达巴万星的现状：研究小组报告。
Int J Antimicrob Agents. 2020 Oct;56(4):106107. doi: 10.1016/j.ijantimicag.2020.106107. Epub 2020 Jul 25.
4
Dalbavancin was effective and safe after one year of treatment in a complicated osteoarticular infection caused by methicillin-resistant Staphylococcus aureus.达巴万星对耐甲氧西林金黄色葡萄球菌引起的复杂性骨关节炎感染进行一年治疗后，疗效显著且安全性良好。
Rev Esp Quimioter. 2021 Aug;34(4):396-399. doi: 10.37201/req/026.2021. Epub 2021 May 6.
5
[Potential indications of dalbavancin in clinical practice].达巴万星在临床实践中的潜在适应证
Enferm Infecc Microbiol Clin. 2017 Jan;35 Suppl 1:38-40. doi: 10.1016/S0213-005X(17)30034-4.
6
Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection.治疗革兰阳性皮肤和软组织感染、骨和关节感染的达巴万星真实世界经验。
Infection. 2019 Dec;47(6):1013-1020. doi: 10.1007/s15010-019-01354-x. Epub 2019 Sep 13.
7
activity of dalbavancin and other anti-staphylococcal agents against infecting isolates of methicillin-resistant coagulase-negative staphylococci.达巴万星和其他抗葡萄球菌药物对耐甲氧西林凝固酶阴性葡萄球菌感染分离株的活性。
J Med Microbiol. 2021 Sep;70(9). doi: 10.1099/jmm.0.001419.
8
French national cohort of first use of dalbavancin: A high proportion of off-label use.法国首用达巴万星的全国队列研究：高比例的超适应证用药。
Int J Antimicrob Agents. 2019 Nov;54(5):668-672. doi: 10.1016/j.ijantimicag.2019.08.006. Epub 2019 Aug 7.
9
Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin.达巴万星治疗耐甲氧西林金黄色葡萄球菌心内膜炎失败
J Clin Pharm Ther. 2018 Feb;43(1):101-103. doi: 10.1111/jcpt.12580. Epub 2017 Jun 19.
10
Dalbavancin: a new lipoglycopeptide antibiotic.达巴万星：一种新型脂糖肽类抗生素。
Am J Health Syst Pharm. 2008 Apr 1;65(7):599-610. doi: 10.2146/ajhp070255.

引用本文的文献

1
Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature.达巴万星作为植入物相关感染的抑制性治疗：一项伴有治疗药物监测的病例系列研究，并对文献进行回顾。
Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1475-1480. doi: 10.1007/s10096-024-04849-0. Epub 2024 May 16.
2
Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety.达巴万星作为人工假体感染患者的抑制性抗生素治疗：疗效与安全性。
Front Pharmacol. 2023 Jun 28;14:1185602. doi: 10.3389/fphar.2023.1185602. eCollection 2023.
3
Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs.

本文引用的文献

1
Serum Bactericidal Activity Levels Monitor to Guide Intravenous Dalbavancin Chronic Suppressive Therapy of Inoperable Staphylococcal Prosthetic Valve Endocarditis: A Case Report.血清杀菌活性水平监测指导达巴万星静脉慢性抑制治疗不可手术的葡萄球菌人工瓣膜心内膜炎：一例报告
Open Forum Infect Dis. 2019 Sep 30;6(11):ofz427. doi: 10.1093/ofid/ofz427. eCollection 2019 Nov.
2
Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study.假体关节感染中的抑制性抗生素治疗：一项多中心队列研究。
Clin Microbiol Infect. 2020 Apr;26(4):499-505. doi: 10.1016/j.cmi.2019.09.007. Epub 2019 Sep 17.
3
French national cohort of first use of dalbavancin: A high proportion of off-label use.
在强化门诊抗菌治疗时代下的达巴万星实际应用：超越获批适应证，关注未满足临床需求的审慎评估。
Drug Des Devel Ther. 2021 Aug 3;15:3349-3378. doi: 10.2147/DDDT.S313756. eCollection 2021.
4
Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review.达巴万星治疗人工关节感染：一项叙述性综述
Antibiotics (Basel). 2021 May 31;10(6):656. doi: 10.3390/antibiotics10060656.
法国首用达巴万星的全国队列研究：高比例的超适应证用药。
Int J Antimicrob Agents. 2019 Nov;54(5):668-672. doi: 10.1016/j.ijantimicag.2019.08.006. Epub 2019 Aug 7.
4
Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.达巴万星治疗骨髓炎和关节炎感染的安全性和疗效。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02280-18. Print 2019 May.
5
Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety.达巴万星治疗成年患者骨髓炎：一项疗效与安全性的随机临床试验
Open Forum Infect Dis. 2018 Dec 10;6(1):ofy331. doi: 10.1093/ofid/ofy331. eCollection 2019 Jan.
6
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna.达巴万星作为革兰阳性菌感染性心内膜炎的初始和序贯治疗：维也纳总医院 2 年经验。
Clin Infect Dis. 2018 Aug 16;67(5):795-798. doi: 10.1093/cid/ciy279.
7
Extended-duration dosing and distribution of dalbavancin into bone and articular tissue.达巴万星的延长给药及在骨骼和关节组织中的分布。
Antimicrob Agents Chemother. 2015 Apr;59(4):1849-55. doi: 10.1128/AAC.04550-14. Epub 2015 Jan 5.
8
Once-weekly dalbavancin versus daily conventional therapy for skin infection.每周一次的达巴万星与每日常规疗法治疗皮肤感染。
N Engl J Med. 2014 Jun 5;370(23):2169-79. doi: 10.1056/NEJMoa1310480.
9
Long-term, once-weekly outpatient teicoplanin use for suppression of chronic prosthetic joint infection.
Int J Antimicrob Agents. 2013 Feb;41(2):200-1. doi: 10.1016/j.ijantimicag.2012.10.006. Epub 2012 Nov 20.